Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | angiotensin-converting enzyme family protein | 0.0376 | 1 | 1 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0135 | 0.0966 | 0.5 |
Echinococcus granulosus | leukotriene A 4 hydrolase | 0.0194 | 0.318 | 0.0611 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0353 | 0.914 | 0.5 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0353 | 0.914 | 0.8806 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0135 | 0.0966 | 0.5 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0353 | 0.914 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0135 | 0.0966 | 0.5 |
Onchocerca volvulus | 0.0184 | 0.2793 | 0.5 | |
Echinococcus multilocularis | dihydrofolate reductase | 0.0353 | 0.914 | 1 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0194 | 0.318 | 0.0538 |
Brugia malayi | dihydrofolate reductase family protein | 0.0353 | 0.914 | 0.8806 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0184 | 0.2793 | 0.3056 |
Brugia malayi | Dihydrofolate reductase | 0.0353 | 0.914 | 0.8806 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0194 | 0.318 | 0.0611 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0353 | 0.914 | 0.5 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0353 | 0.914 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0135 | 0.0966 | 0.5 |
Echinococcus granulosus | dihydrofolate reductase | 0.0353 | 0.914 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0135 | 0.0966 | 0.5 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0194 | 0.318 | 0.348 |
Schistosoma mansoni | dihydrofolate reductase | 0.0353 | 0.914 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0135 | 0.0966 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.